(OTIC) |
| 0 (0%) 10-12 13:52 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 11.53 |
| Resistance 1: | 9.88 |
| Pivot price: | 8.71 |
| Support 1: | 8.79 |
| Support 2: | 8.13 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -0.640 |
| Book Value | 9.530 |
| PEG Ratio | 0.00 |
| Gross Profit | 3.194 |
| Profit Margin (%) | -5.64 |
| Operating Margin (%) | 1.86 |
| Return on Assets (ttm) | 0.1 |
| Return on Equity (ttm) | -7.1 |
Company news
Wed, 07 Oct 2026
Blue Owl’s OTIC: Line Up, Line Up: Part II - Substack
Sun, 04 Oct 2026
What Is Neomycin Polymyxin B Sulfates and Hydrocortisone Otic Solution USP? - www.polskieradio.pl
Fri, 02 Oct 2026
Blue Owl maintains 5% tender cap on two BDCs amid elevated withdrawal requests - TradingView
Thu, 01 Oct 2026
Ohio Turnpike E-ZPass customers can now use their transponders in 4 more states - Mahoning Matters
Thu, 01 Oct 2026
Cronus Pharma Announces the Launch of Florfinasone™ Otic for the Treatment of Otitis Externa in Dogs - Yahoo Finance
Thu, 01 Oct 2026
Cronus Pharma Announces the Launch of Florfinasone™ Otic for the Treatment of Otitis Externa in Dogs - Business Wire
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
